5. Liquid Biopsies
At Pathology 2026, Minimally invasive testing using blood or fluids to detect disease markersIt enables detection of circulating biomarkers without surgical intervention. Enhances precision detection without surgical intervention
Key Highlights:
5.1 Circulating tumor DNA
5.2 Exosome analysis
5.3 Real-time monitoring
5.4 Early cancer detection
5.5 Treatment response tracking